more info

Start date: 1 June 2016

End date: 31 December 2023

Number of projects: 5

Total budget: 10 151 737,24 €

EU contribution: 5 047 126,11 €

Website: n/a

Country:

European Commission Flag

Explore more: n/a

funds

ERDF: 5 047 126,11 €

ADAMED PHARMA SPÓŁKA AKCYJNA

1 - 5 of 5

PROJECT

TOTAL BUDGET

EU CONTRIBUTION

FUND

Development and implementation of an innovative medicinal product in the form of an ODT tablet containing the second generation antipsychotic substance.

3 067 134,89 €

1 876 417,85 €

ERDF

Development of an innovative urological drug with Furazidin, a response to increasing drug resistance to urinary tract infections

4 155 340,15 €

1 733 667,57 €

ERDF

Development and implementation of an innovative combination of cardiovascular polytherapy with associated risk factors

1 425 922,49 €

702 645,98 €

ERDF

Development and implementation of a modern form of drug with easy application, inhibiting androgenic alopecia and stimulating hair regrowth in both women and men.

650 363,33 €

393 204,16 €

ERDF

LabGears: development and implementation of a web application for R & D data management and analysis

852 976,38 €

341 190,55 €

ERDF